Stepan Company (SCL): Price and Financial Metrics


Stepan Company (SCL): $117.95

-0.30 (-0.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SCL to Watchlist
Sign Up

Industry: Chemicals


Ranked

of 99

in industry

SCL POWR Grades


  • Stability is the dimension where SCL ranks best; there it ranks ahead of 96.78% of US stocks.
  • SCL's strongest trending metric is Momentum; it's been moving up over the last 31 weeks.
  • SCL ranks lowest in Growth; there it ranks in the 39th percentile.

SCL Stock Summary

  • SCL's went public 29.39 years ago, making it older than 80.23% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of 23.47%, Stepan Co's debt growth rate surpasses 78.03% of about US stocks.
  • The volatility of Stepan Co's share price is greater than that of merely 3.11% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Stepan Co are THRM, HWKN, MLI, HELE, and MTH.
  • SCL's SEC filings can be seen here. And to visit Stepan Co's official web site, go to www.stepan.com.

SCL Valuation Summary

  • In comparison to the median Basic Materials stock, SCL's EV/EBIT ratio is 17.51% lower, now standing at 14.6.
  • Over the past 243 months, SCL's EV/EBIT ratio has gone up 3.9.
  • Over the past 243 months, SCL's price/sales ratio has gone up 1.1.

Below are key valuation metrics over time for SCL.

Stock Date P/S P/B P/E EV/EBIT
SCL 2019-05-23 1.0 2.3 17.8 13.6
SCL 2012-07-25 0.5 2.1 12.3 8.9
SCL 2011-12-21 0.5 2.1 12.5 9.4
SCL 2008-07-11 0.3 1.9 23.5 15.2
SCL 2006-11-16 0.2 1.5 23.3 17.3
SCL 2005-01-19 0.2 1.2 33.1 22.6

SCL Growth Metrics

  • The 4 year net cashflow from operations growth rate now stands at 40.87%.
  • Its 3 year price growth rate is now at 44.44%.
  • Its 3 year net cashflow from operations growth rate is now at 18.53%.
SCL's revenue has moved up $146,396,000 over the prior 67 months.

The table below shows SCL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 1,957.503 229.993 139.836
2020-12-31 1,869.75 235.216 126.77
2020-09-30 1,820.006 227.457 118.458
2020-06-30 1,807.108 198.175 111.179
2020-03-31 1,819.562 207.517 105.69
2019-12-31 1,858.745 218.428 103.129

SCL Price Target

For more insight on analysts targets of SCL, see our SCL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $141.50 Average Broker Recommendation 1.67 (Moderate Buy)

SCL Stock Price Chart Interactive Chart >

Price chart for SCL

SCL Price/Volume Stats

Current price $117.95 52-week high $139.30
Prev. close $118.25 52-week low $105.96
Day low $117.00 Volume 321,066
Day high $119.86 Avg. volume 74,335
50-day MA $125.34 Dividend yield 1.03%
200-day MA $124.15 Market Cap 2.66B

Stepan Company (SCL) Company Bio


Stepan Chemical is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning compounds. The Company is also a leading supplier of Polyurethane polyols used in the expanding thermal insulation market, and C.A.S.E. (Coatings, Adhesives, Sealants, and Elastomers) industries. The company was founded in 1932 and is based in Northfield, Illinois.

SCL Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$117.95$84.48 -37%

We started the process of determining a valid price forecast for Stepan Co with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Stepan Co ranked in the 42th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 36.83%. As for the metrics that stood out in our discounted cash flow analysis of Stepan Co, consider:

  • SCL's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 39.36% of tickers in our DCF set.
  • Stepan Co's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 33.93. This coverage rate is greater than that of 87.07% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • Relative to other stocks in its sector (Basic Materials), Stepan Co has a reliance on debt greater than just 19.71% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-38%
1%-38%
2%-37%
3%-37%
4%-36%
5%-35%

Want more companies with a valuation profile/forecast similar to that of Stepan Co? See AA, CSTM, GCP, PPG, and CE.


SCL Latest News Stream


Event/Time News Detail
Loading, please wait...

SCL Latest Social Stream


Loading social stream, please wait...

View Full SCL Social Stream

Latest SCL News From Around the Web

Below are the latest news stories about Stepan Co that investors may wish to consider to help them evaluate SCL as an investment opportunity.

Stepan Co. (SCL) Misses Q2 Earnings Estimates

Stepan Co. (SCL) delivered earnings and revenue surprises of -1.63% and 9.18%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | July 28, 2021

Stepan Reports Record Second Quarter Results and Record First Half Earnings

Stepan Company (NYSE: SCL) today reported:

Yahoo | July 28, 2021

Stepan Declares Quarterly Dividend

Stepan Company (NYSE:SCL) today reported:

Yahoo | July 28, 2021

The Returns At Stepan (NYSE:SCL) Aren't Growing

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...

Yahoo | July 26, 2021

Dha Powder For Dietary Supplements Sales Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:DSM, Stepan Company, Novotech Nutraceuticals, Lonza, Arjuna Natural, Ru

This report studies the Dha Powder For Dietary Supplements Sales Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Dha Powder For Dietary []

Jumbo News | July 24, 2021

Read More 'SCL' Stories Here

SCL Price Returns

1-mo -1.93%
3-mo -9.52%
6-mo 5.18%
1-year 9.68%
3-year 39.08%
5-year 93.56%
YTD -0.67%
2020 17.75%
2019 39.96%
2018 -5.21%
2017 -2.05%
2016 65.99%

SCL Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SCL Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8779 seconds.